Plerixafor Injection Market Outlook, Trends And Future Opportunities (2024-2031)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Plerixafor Injection Market

Plerixafor Injection Market Outlook, Trends And Future Opportunities (2024-2031)

Plerixafor Injection Market, By Type (Prefilled Syringe, Injectable, Lyophilized), By Hematopoietic Stem Cell Transplantation Type (Autologous, Allogeneic), By End-user (Hospitals, Specialty Clinics, Stem Cell Banks, Others), By Combination Therapy (Plerixafor + GCSF, Plerixafor + Chemo + GCSF, Others), By Application (Non-Hodgkin’s Lymphoma, Multiple Myeloma, Hodgkin’s Lymphoma, Acute Myeloid Leukemia, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Mar 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA59
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Plerixafor Injection Market is Forecasted to Hit US$ 1,011.5 Mn By 2031 | CAGR 7.2%

Table Of Contents:

Chapter 1. Research Methodology and Scope

  • Market Segmentation and Scope
  • Regional Coverage
  • Objectives
  • Research Methodology

Chapter 2. Executive Summary

  • Market Landscape
  • Market Size & Forecast
  • Competitive Landscape

Chapter 3. Plerixafor Injection Market: By Type Segment Market Trends, Size, and Future Outlook

  • By Type Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Type Definitions, Technology Landscape
  • By Type Market Drivers
    • Product Launches
    • Technology Launches
    • Other drivers
  • By Type Market Restraints

Chapter 4. Plerixafor Injection Market: By Hematopoietic Stem Cell Transplantation Type Segment Market Trends, Size, and Future Outlook

  • By Hematopoietic Stem Cell Transplantation Type Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Hematopoietic Stem Cell Transplantation Type Definitions, Technology Landscape
  • By Hematopoietic Stem Cell Transplantation Type Market Drivers
  • By Hematopoietic Stem Cell Transplantation Type Market Restraints

Chapter 5. Plerixafor Injection Market: By End-user Segment Market Trends, Size, and Future Outlook

  • By End-user Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By End-user Definitions, Technology Landscape
  • By End-user Market Drivers
  • By End-user Market Restraints

Chapter 6. Plerixafor Injection Market: By Combination Therapy Segment Market Trends, Size, and Future Outlook

  • By Combination Therapy Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Combination Therapy Definitions, Technology Landscape
  • By Combination Therapy Market Drivers
  • By Combination Therapy Market Restraints

Chapter 7. Plerixafor Injection Market: By Application Segment Market Trends, Size, and Future Outlook

  • By Application Segment Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Application Definitions, Technology Landscape
  • By Application Market Drivers
  • By Application Market Restraints

Chapter 8. Plerixafor Injection Market: Regional Market Trends, Size, and Future Outlook

  • North America Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • North America Definitions, Technology Landscape
  • North America Market Drivers
  • North America Market Restraints
  • Competitive Outlook

Chapter 9. Plerixafor Injection Market: Europe Market Trends, Size, and Future Outlook

  • Europe Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Europe Definitions, Technology Landscape
  • Europe Market Drivers
  • Europe Market Restraints
  • Competitive Outlook

Chapter 10. Plerixafor Injection Market: Asia Pacific Market Trends, Size, and Future Outlook

  • Asia Pacific Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Asia Pacific Definitions, Technology Landscape
  • Asia Pacific Market Drivers
  • Asia Pacific Market Restraints
  • Competitive Outlook

Chapter 11. Plerixafor Injection Market: Latin America Market Trends, Size, and Future Outlook

  • Latin America Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Latin America Definitions, Technology Landscape
  • Latin America Market Drivers
  • Latin America Market Restraints
  • Competitive Outlook

Chapter 12. Plerixafor Injection Market: Middle East & Africa Market Trends, Size, and Future Outlook

  • Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Middle East & Africa Definitions, Technology Landscape
  • Middle East & Africa Market Drivers
  • Middle East & Africa Market Restraints
  • Competitive Outlook

Chapter 13. Plerixafor Injection Market: Competitive Landscape

  • Genzyme Corporation
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Sanofi S.A
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Cadila Healthcare
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Mylan N.V.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • IDsA Generics
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Cipla Ltd.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Sun Pharmaceutical
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Dr. Reddy’s Laboratories Ltd.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Accord Healthcare
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Natco Pharma
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Biocon Ltd.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Intas Pharmaceuticals
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
  • Pfizer Inc.
    • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
    • Other companies
  • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size is USD 580 million in 2024.

Rising prevalence of blood cancers, growth of stem cell transplantation procedures globally, entry of biosimilars, and technology advancements.

High costs of treatment, low awareness levels in developing regions, complex regulatory pathways for new products.

The prefilled syringe segment accounts for over 40% share owing to ease of administration.

Genzyme Corporation, Sanofi, Cadila Healthcare, Mylan N.V., Dr Reddy's Laboratories, Cipla Ltd., among others.

The market is projected to grow at a CAGR of 7.2% to reach USD 1,011.5 million by 2031.

Increasing blood cancer incidence, rising stem cell transplantations, new product launches, and growth in developed regions like North America.
Download FREE Sample Buy Now